Press Releases
Infinity Venture Group Introduces Innovative
Venture Development Model
Rockville, Maryland (April 7, 2003) – A seasoned
group of start-up veterans has launched a seed-stage development
company, Infinity Venture Group (IVG), which will employ a unique
approach to commercializing technology. IVG will develop a portfolio
of early stage ventures around university and laboratory
technologies in a way that is more active and hands-on than
traditional venture capitalists that merely read and fund business
plans.
“A massive backlog of new research is emerging from universities,
commercial labs, and government contractors, funded by double digit
growth in public grant funding and corporate R&D spending over the
last five years.” says Ed Addison, Executive Director at IVG. “The
current economic climate makes it extremely difficult to
commercialize this new technology based on traditional VC funding or
corporate capital. IVG uses a multi-faceted business model that
combines a ‘services-for-equity’ agreement with seed funding,
providing the necessary ingredients to move technology into
commercial markets.”
Much of IVG’s early following is the result of demand created by
Addison’s new book, “Leveraging the Horizon: Secrets of a Serial
Entrepreneur” which documents his experience with seed-stage
ventures.
The IVG management team is leveraging their previous experience
launching new ventures as part of the model. The core group of
principals has managed, from inception to exit, a number of
high-tech ventures including ConQuest Software, Powerize.com, and
BioSequent Informatics. Both ConQuest and Powerize are now part of
successful public companies and BioSequent is commercializing new
distributed data management software for the bioinformatics market.
John McGrath, Managing Director, describes IVG’s approach. “The
success of our commercialization process is based on the integration
of three primary functions at IVG: Our Venture Development Group,
which applies managerial know-how, the Commercialization Foundry™,
which provides engineering, marketing, and operational services, and
our Germination Funding™, which invests the necessary dollars to get
our projects to initial product release or licensing.”
IVG has a pipeline of ventures underway in emerging markets
including bioinformatics, Web services, and homeland security
applications. Recently, both Addison and McGrath have been managing
education and research programs at Johns Hopkins University and the
University of Massachusetts, respectively.
“Technology owners are interested in IVG because of our proven
ability to get their innovations to market quickly with very
attractive financial arrangements and minimal cash involvement,”
says Ted Bagheri, Managing Director and CFO of Infinity Venture
Group. “Investors are attracted to the lower risk/ higher ROI of our
company structure. It provides the economic benefits of seed stage
fund investing without the inherent risk. Our model is highly
flexible so we can dynamically manage valuation growth and periodic
distribution to our shareholders, even when the marketplace takes a
left turn.”
About Infinity Venture Group
Infinity Venture Group provides comprehensive venture management
consulting and capital to maximize the commercial value of
technology. We help to define, fund, and execute profitable
information technology, life sciences, greentech, and alternative
energy ventures. Infinity Venture Group has established relationships with universities,
government and corporate labs and has extensive experience
transitioning technology from the laboratory to the marketplace. For
information visit www.infinityvg.com.
For information about Addison’s “Leveraging the Horizon” visit
ww.leveragingthehorizon.com.
###
|